Cidara Therapeutics, Inc.
Q2 2025 13F Holders
Symbol
CDTX
CUSIP
171757206
Type
Equity
Class
COM NEW
Num filings
124
Total reported value, excl. options
$1.26 B
Compare 2025 Q2 to
2025 Q4
2025 Q3
2025 Q1
2024 Q4
2024 Q3
2024 Q2
Manager
Report Date
Value ($000)
Shares
Option Type